A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain

NCT02171182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 319

Last updated 2016-02-08

No results posted yet for this study

Summary

The aim of this study is to monitor the effectiveness and used dosage of the 8% capsaicin patch in real-life clinical practice in the treatment of post-operative neuropathic pain.

Conditions

  • Post-operative Peripheral Neuropathic Pain

Interventions

DRUG

Qutenza

capsaicin patch

Sponsors & Collaborators

  • Astellas Pharma s.r.o.

    lead INDUSTRY

Principal Investigators

  • Medical and Scientific Affairs manager · Astellas Pharma s.r.o.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02171182 on ClinicalTrials.gov